Simplex Trading’s Astria Therapeutics ATXS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-2,100
| Closed | -$27.5K | – | 9024 |
|
|
2025
Q4 | $27.5K | Buy |
+2,100
| New | +$25.1K | ﹤0.01% | 6185 |
|
|
2025
Q2 | – | Sell |
-600
| Closed | -$3K | – | 8591 |
|
|
2025
Q1 | $3K | Buy |
+600
| New | +$4.2K | ﹤0.01% | 7776 |
|
|
2024
Q4 | – | Sell |
-700
| Closed | -$7K | – | 8469 |
|
|
2024
Q3 | $7K | Sell |
700
-7,700
| -92% | -$85.6K | ﹤0.01% | 7397 |
|
|
2024
Q2 | $76K | Sell |
8,400
-8,500
| -50% | -$83K | ﹤0.01% | 5654 |
|
|
2024
Q1 | $237K | Buy |
16,900
+16,700
| +8,350% | +$208K | ﹤0.01% | 4656 |
|
|
2023
Q4 | $1K | Sell |
200
-2,300
| -92% | -$12.7K | ﹤0.01% | 8429 |
|
|
2023
Q3 | $18K | Sell |
2,500
-2,400
| -49% | -$20.5K | ﹤0.01% | 6693 |
|
|
2023
Q2 | $40K | Buy |
+4,900
| New | +$56.5K | ﹤0.01% | 6050 |
|
|
2023
Q1 | – | Sell |
-2,300
| Closed | -$34K | – | 8980 |
|
|
2022
Q4 | $34K | Buy |
2,300
+1,800
| +360% | +$18.6K | ﹤0.01% | 6296 |
|
|
2022
Q3 | $4K | Buy |
+500
| New | +$3.35K | ﹤0.01% | 8875 |
|
|
2022
Q2 | – | Sell |
-300
| Closed | -$2K | – | 9907 |
|
|
2022
Q1 | $2K | Buy |
+300
| New | +$1.79K | ﹤0.01% | 9816 |
|
|
2021
Q3 | – | Sell |
-100
| Closed | -$1K | – | 9749 |
|
|
2021
Q2 | $1K | Buy |
100
+24
| +32% | +$312 | ﹤0.01% | 9791 |
|
|
2021
Q1 | $131K | Buy |
76
+66
| +660% | +$1.19K | ﹤0.01% | 5364 |
|
|
2020
Q4 | $12K | Buy |
+10
| New | +$178 | ﹤0.01% | 7287 |
|
Simplex Trading's ATXS Position: Q1 2026 in Review
Simplex Trading sold out of Astria Therapeutics (ATXS) in Q1 2026, closing a stake of 3,257 shares — an estimated $42.6K sold.
Simplex Trading first reported a position in ATXS in Q4 2020 and held it in 17 quarters. The position peaked at $1.36M in Q1 2024. 0 funds tracked by Wall St. Rank hold ATXS as of Q1 2026.
- Simplex Trading reported no remaining Astria Therapeutics position as of Q1 2026 after selling out during the quarter.
- Simplex Trading sold 3,257 Astria Therapeutics shares in Q1 2026, an estimated $42.6K.
- Simplex Trading first reported a position in Astria Therapeutics in Q4 2020 and held it in 17 quarters.
- Simplex Trading's Astria Therapeutics position peaked at $1.36M in Q1 2024.
- 0 funds tracked by Wall St. Rank held Astria Therapeutics as of Q1 2026.
Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.